Clinical Trial Update: Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids [Phase 3]

View source ↗

Summary

Phase 3 study comparing concentration-controlled everolimus with reduced-dose cyclosporine versus mycophenolate mofetil with standard-dose cyclosporine in adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Basiliximab (basiliximab)
• CYCLOSPORINE (cyclosporine)
• Everolimus (everolimus)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Novartis | Conditions: Kidney Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2011-09-14